DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2

p53, the cellular gatekeeper for growth and division

Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693

Mdm2 promotes the rapid degradation of p53

Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506

Regulation of p53 stability by Mdm2

Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., & Fornace, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90593-2 · Cited by 3,047

A Single Ataxia Telangiectasia Gene with a Product Similar to PI-3 Kinase

Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., et al. (1995) · Science · doi:10.1126/science.7792600 · Cited by 2,785

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346

Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation Domain

Kussie, P. H., Gorina, S., Marechal, V., Elenbaas, B., Moreau, J., Levine, A. J., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.948 · Cited by 2,206

The p53-mdm-2 autoregulatory feedback loop.

Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,474

The ATDC (TRIM29) Protein Binds p53 and Antagonizes p53-Mediated Functions

Yuan, Z., Villagra, A., Peng, L., Coppola, D., Glozak, M. A., Sotomayor, E. M., Chen, J., Lane, W. S., & Seto, E. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01023-09 · Cited by 116

Interaction of p53 and DNA-PK in response to nucleoside analogues: potential role as a sensor complex for DNA damage.

Achanta, G., Pelicano, H., Feng, L., Plunkett, W. K., & Huang, P. (2001) · PubMed · Cited by 115

RPA and ATR link transcriptional stress to p53

Derheimer, F. A., O’Hagan, H. M., Krueger, H., Hanasoge, S., Paulsen, M. T., & Ljungman, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705317104 · Cited by 119

Role of homologous recombination in carcinogenesis

Bishop, A. J. R., & Schiestl, R. H. (2003) · Experimental and Molecular Pathology · doi:10.1016/s0014-4800(03)00010-8 · Cited by 114

HIV induces lymphocyte apoptosis by a p53‐initiated, mitochondrial‐mediated mechanism

Genini, D., Sheeter, D. A., Rought, S. E., Zaunders, J. J., Susín, S. A., Kroemer, G., Richman, D. D., Carson, D. A., Corbeil, J., & Leoni, L. M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0336fje · Cited by 114

Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture.

Freedman, D. A., & Levine, A. J. (1999) · PubMed · Cited by 114

LncRNA Meg3 protects endothelial function by regulating the DNA damage response

Ali, M. S. S. H., Cheng, X., Moran, M., Haemmig, S., Naldrett, M. J., Alvarez, S., Feinberg, M. W., & Sun, X. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1190 · Cited by 113

Activation of p53 by oncogenes.

Lowe, S. W. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060045 · Cited by 117

Conjugation of vitamin E analog α-TOS to Pt(iv) complexes for dual-targeting anticancer therapy

Suntharalingam, K., Song, Y., & Lippard, S. J. (2013) · Chemical Communications · doi:10.1039/c3cc48740g · Cited by 112

A “Twist box” Code of p53 Inactivation: Twist box:p53 Interaction Promotes p53 Degradation

Piccinin, S., Tonin, E., Sessa, S., Demontis, S., Rossi, S., Pecciarini, L., Zanatta, L., Pivetta, F., Grizzo, A., Sonego, M., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.003 · Cited by 121

DNA-PK, ATM and ATR collaboratively regulate p53–RPA interaction to facilitate homologous recombination DNA repair

Serrano, M. A., Li, Z., Dangeti, M., Musich, P. R., Patrick, S., Roginskaya, M., Cartwright, B., & Zou, Y. (2012) · Oncogene · doi:10.1038/onc.2012.257 · Cited by 124

p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53

Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debüssche, L., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202528 · Cited by 112

LKB1 Is Recruited to the p21/WAF1 Promoter by p53 to Mediate Transcriptional Activation

Zeng, P.-Y., & Berger, S. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0999 · Cited by 112

Connective Tissue Growth Factor and Regulation of the Mesangial Cell Cycle

Wahab, N. A., Weston, B. S., Roberts, T., & Mason, R. M. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000031828.58276.02 · Cited by 113

Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin

Lim, D. Y., & Park, J. H. Y. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90490.2008 · Cited by 111

p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status

Quintás‐Cardama, A., Hu, C., Qutub, A. A., Qiu, Y. H., Zhang, X., Post, S. M., Zhang, N., Coombes, K. R., & Kornblau, S. M. (2016) · Leukemia · doi:10.1038/leu.2016.350 · Cited by 116

A small molecule Inauhzin inhibits SIRT1 activity and suppresses tumour growth through activation of p53

Zhang, Q., Zeng, S. X., Zhang, Y., Zhang, Y.-W., Ding, D., Ye, Q.-Z., Meroueh, S. O., & Lu, H. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100211 · Cited by 110

Oxidative stress pathways involved in cytotoxicity and genotoxicity of titanium dioxide (TiO2) nanoparticles on cells constitutive of alveolo-capillary barrier in vitro

Hanot, M., Tubeuf, E., Guilbert, A., Bado‐Nilles, A., Vigneron, P., Trouiller, B., Braun, A., & Lacroix, G. (2016) · Toxicology in Vitro · doi:10.1016/j.tiv.2016.01.013 · Cited by 110

Induction of the TRAIL receptor KILLER/DR5 in p53-dependent apoptosis but not growth arrest

Wu, G. S., Burns, T. F., McDonald, E. R., Meng, R. D., Kao, G. D., Muschel, R. J., Yen, T. J., & El‐Deiry, W. S. (1999) · Oncogene · doi:10.1038/sj.onc.1203025 · Cited by 109

The Mammalian Cell Cycle: An Overview

Harper, J. V., & Brooks, G. (2004) · Humana Press eBooks · doi:10.1385/1-59259-857-9:113 · Cited by 112

The Proline Repeat Domain of p53 Binds Directly to the Transcriptional Coactivator p300 and Allosterically Controls DNA-Dependent Acetylation of p53

Dornan, D., Shimizu, H., Burch, L. R., Smith, A. J., & Hupp, T. R. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.23.8846-8861.2003 · Cited by 108

Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death

Lee, J.-H., Kim, H.-S., Lee, S., & Kim, K. (2007) · Journal of Cell Science · doi:10.1242/jcs.03468 · Cited by 110

Degradation of Phosphorylated p53 by Viral Protein-ECS E3 Ligase Complex

Sato, Y., Kamura, T., Shirata, N., Murata, T., Kudoh, A., Iwahori, S., Nakayama, S., Isomura, H., Nishiyama, Y., & Tsurumi, T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000530 · Cited by 113

The Cell Cycle-regulated Protein Human GTSE-1 Controls DNA Damage-induced Apoptosis by Affecting p53 Function

Monte, M., Benetti, R., Buscemi, G., Sandy, P., Sal, G. D., & Schneider, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302902200 · Cited by 107

The onset of p53-dependent DNA repair or apoptosis is determined by the level of accumulated damaged DNA

Offer, H., Erez, N., Zurer, I., Tang, X., Milyavsky, M., Goldfinger, N., & Rotter, V. (2002) · Carcinogenesis · doi:10.1093/carcin/23.6.1025 · Cited by 112

The Cyclin-Dependent Kinase Inhibitor Roscovitine Inhibits RNA Synthesis and Triggers Nuclear Accumulation of p53 That Is Unmodified at Ser15 and Lys382

Ljungman, M. E., & Paulsen, M. T. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12306-1 · Cited by 107

Collagenase and gelatinase activities in bronchoalveolar lavage fluids during bleomycin-induced lung injury

Bakowska, J., & Adamson, I. Y. R. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199807)185:3 · Cited by 47

Regulation of apoptosis by p53 in UV-irradiated human epidermis, psoriatic plaques and senescent keratinocytes

Qin, J., Chaturvedi, V., Denning, M. F., Bacon, P. E., Panella, J., Choubey, D., & Nickoloff, B. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205404 · Cited by 108

ATM Phosphorylation of Mdm2 Ser394 Regulates the Amplitude and Duration of the DNA Damage Response in Mice

Gannon, H. S., Woda, B. A., & Jones, S. N. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.011 · Cited by 105

Trp-tRNA synthetase bridges DNA-PKcs to PARP-1 to link IFN-γ and p53 signaling

Sajish, M., Zhou, Q., Kishi, S., Valdez, D. M., Kapoor, M., Guo, M., Lee, S. H., Kim, S., Yang, X., & SCHIMMEL, P. R. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.937 · Cited by 115

The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenancePreprint

van Riggelen, J., Müller, J., Otto, T., Beuger, V., Yetil, A., Choi, P. S., Kosan, C., Möröy, T., Felsher, D. W., & Eilers, M. (2010) · Genes & Development · doi:10.1101/gad.585710 · Cited by 113

Increase in wild-type p53 stability and transactivational activity by the chemopreventive agent apigenin in keratinocytes

McVean, M., Xiao, H., Isobe, K., & Pelling, J. C. (2000) · Carcinogenesis · doi:10.1093/carcin/21.4.633 · Cited by 104

Grape Seed Proanthocyanidins Induce Apoptosis through p53, Bax, and Caspase 3 Pathways

Roy, A. M., Baliga, M. S., Elmets, C. A., & Katiyar, S. K. (2005) · Neoplasia · doi:10.1593/neo.04412 · Cited by 105

Nitric oxide promotes p53 nuclear retention and sensitizes neuroblastoma cells to apoptosis by ionizing radiation

Wang, X., Zalcenstein, A., & Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401181 · Cited by 107

4-Hydroxynonenal induces p53-mediated apoptosis in retinal pigment epithelial cells

Sharma, A., Sharma, R., Chaudhary, P., Vatsyayan, R., Pearce, V., Jeyabal, P., Zimniak, P., Awasthi, S., & Awasthi, S. (2008) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2008.09.016 · Cited by 106

Inhibition of AMP-activated Protein Kinase α (AMPKα) by Doxorubicin Accentuates Genotoxic Stress and Cell Death in Mouse Embryonic Fibroblasts and Cardiomyocytes

Wang, S., Song, P., & Zou, M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.315812 · Cited by 111

Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells

Jiang, C., Hu, H., Malewicz, B., Wang, Z., & Lü, J. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.877.3.7 · Cited by 104

Bach1 inhibits oxidative stress–induced cellular senescence by impeding p53 function on chromatin

Dohi, Y., Ikura, T., Hoshikawa, Y., Katoh, Y., Ota, K., Nakanome, A., Muto, A., Omura, S., Ohta, T., Ito, A., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1516 · Cited by 104

Role of p38 and JNK MAPK signaling pathways and tumor suppressor p53 on induction of apoptosis in response to Ad-eIF5A1 in A549 lung cancer cells

Taylor, C. A., Zheng, Q., Liu, Z., & Thompson, J. E. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-35 · Cited by 104

Mutation of Mouse p53 Ser23 and the Response to DNA Damage

Wu, Z., Earle, J., Saito, S., Anderson, C. W., Appella, E., & Xu, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.8.2441-2449.2002 · Cited by 103

Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion

Khan, S. H., Moritsugu, J., & Wahl, G. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3266 · Cited by 103

Severe acute respiratory syndrome coronavirus 3a protein activates the mitochondrial death pathway through p38 MAP kinase activation

Padhan, K., Minakshi, R., Towheed, A., & Jameel, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83665-0 · Cited by 103

Endoplasmic Reticulum Stress Stimulates p53 Expression through NF-κB Activation

Lin, W.-C., Chuang, Y.-C., Chang, Y.-S., Lai, M.-D., Teng, Y., Su, I., Wang, C. C. C., Lee, K.-H., & Hung, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039120 · Cited by 104

The Essential Role of p53 in Hyperpigmentation of the Skin via Regulation of Paracrine Melanogenic Cytokine Receptor Signaling

Murase, D., Hachiya, A., Amano, Y., Ohuchi, A., Kitahara, T., & Takema, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805570200 · Cited by 106

Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis

Stefano, V. D., Rinaldo, C., Sacchi, A., Soddu, S., & D’Orazi, G. (2003) · Experimental Cell Research · doi:10.1016/j.yexcr.2003.09.032 · Cited by 103

ZBP-89 Promotes Growth Arrest through Stabilization of p53

Bai, L., & Merchant, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4670-4683.2001 · Cited by 103

Small-molecule MDM2 inhibitors in clinical trials for cancer therapy

Wang, S., & Chen, F. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114334 · Cited by 104

Human bronchial epithelial BEAS-2B cells, an appropriate in vitro model to study heavy metals induced carcinogenesis

Park, Y.-H., Kim, D., Dai, J., & Zhang, Z. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.06.008 · Cited by 104

Sumoylation of Mdm2 by Protein Inhibitor of Activated STAT (PIAS) and RanBP2 Enzymes

Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T., & Yasuda, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208319200 · Cited by 102

Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression

Arizti, P., Li, F., Park, I., Yin, Y., Solomon, E., Ouchi, T., Aaronson, S. A., & Lee, S. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7450-7459.2000 · Cited by 102

Radiation-Induced p53 and p21WAF–1/CIP1 Expression in the Murine Intestinal Epithelium

Wilson, J. W., Pritchard, D. M., Hickman, J. A., & Potten, C. S. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65631-3 · Cited by 102

Site-specific NMR mapping and time-resolved monitoring of serine and threonine phosphorylation in reconstituted kinase reactions and mammalian cell extracts

Theillet, F., Rose, H. M., Liokatis, S., Binolfi, A., Thongwichian, R., Stuiver, M., & Selenko, P. (2013) · Nature Protocols · doi:10.1038/nprot.2013.083 · Cited by 101

Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines

Rozenblat, S., Grossman, S., Bergman, M., Gottlieb, H. E., Cohen, Y. R., & Dovrat, S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.024 · Cited by 103

Conditional ablation of Ikkb inhibits melanoma tumor development in mice

Yang, J., Splittgerber, R. C., Yull, F. E., Kantrow, S. M., Ayers, G. D., Karin, M., & Richmond, A. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42358 · Cited by 102

Benzo[a]pyrene-induced DNA damage and p53 modulation in human hepatoma HepG2 cells for the identification of potential biomarkers for PAH monitoring and risk assessment

Park, S., Lee, S., Ye, S., Yoon, S., Chung, M., & Choi, J. (2006) · Toxicology Letters · doi:10.1016/j.toxlet.2006.08.011 · Cited by 101

Alterations of the p16-pRb Pathway and the Chromosome Locus 9p21–22 in Non-Small-Cell Lung Carcinomas

Gorgoulis, V. G., Zacharatos, P., Kotsinas, A., Liloglou, T., Kyroudi, A., Veslemes, M., Rassidakis, A., Halazonetis, T. D., Field, J. K., & Kittas, C. N. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65690-8 · Cited by 101

Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death

Awasthi, S., Sharma, R., Sharma, A., Yadav, S., Singhal, S. S., Chaudhary, P., & Awasthi, S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.04.007 · Cited by 101

DNA damage response of A549 cells treated with particulate matter (PM 10 ) of urban air pollutants

Sánchez-Pérez, Y., Chirino, Y. I., Osornio-Vargas, Á. R., Morales‐Bárcenas, R., Gutiérrez‐Ruíz, M. C., Vázquez‐López, I., & García-Cuellar, C. M. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.01.010 · Cited by 100

FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage

Chung, Y. M., Park, S., Tsai, W.-B., Wang, S., Ikeda, M.-A., Berek, J. S., Chen, D. J., & Hu, M. C. ‐. (2012) · Nature Communications · doi:10.1038/ncomms2008 · Cited by 104

p53-Mediated Regulation of Proliferating Cell Nuclear Antigen Expression in Cells Exposed to Ionizing Radiation

Xu, J., & Morris, G. F. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.12 · Cited by 102

Questioning the Role of Checkpoint Kinase 2 in the p53 DNA Damage Response

Ahn, J., Urist, M., & Prives, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213185200 · Cited by 99

Luteolin sensitizes the anticancer effect of cisplatin via c-Jun NH2-terminal kinase–mediated p53 phosphorylation and stabilization

Shi, R., Huang, Q., Zhu, X., Ong, Y. B., Zhao, B., Lu, J., Ong, C. N., & Shen, H. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0638 · Cited by 100

Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway

Deriano, L. (2005) · Blood · doi:10.1182/blood-2004-07-2888 · Cited by 99

The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association

Nagata, Y., Anan, T., Yoshida, T., Mizukami, T., Taya, Y., Fujiwara, T., Kato, H., Saya, H., & Nakao, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202978 · Cited by 99

A Role for p53 in Maintaining and Establishing the Quiescence Growth Arrest in Human Cells

Itahana, K., Dimri, G. P., Hara, E., Itahana, Y., Zou, Y., Desprez, P., & Campisi, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201028200 · Cited by 100

Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?

Thomas, A., Kelly, G. L., & Strasser, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00996-z · Cited by 102

p53 Localization at Centrosomes during Mitosis and Postmitotic Checkpoint Are ATM-dependent and Require Serine 15 Phosphorylation

Tritarelli, A., Oricchio, E., Ciciarello, M., Mangiacasale, R., Palena, A., Lavia, P., Soddu, S., & Cundari, E. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-12-0900 · Cited by 104

Adenovirus E1B 55-Kilodalton Oncoprotein Inhibits p53 Acetylation by PCAF

Liu, Y., Colosimo, A. L., Yang, X., & Liao, D. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5540-5553.2000 · Cited by 98

Bisphenol AF negatively affects oocyte maturation of mouse in vitro through increasing oxidative stress and DNA damage

Ding, Z., Jiao, X., Wu, D., Zhang, J., Chen, F., Wang, Y., Huang, C., Zhang, S.-X., Li, X. O., & Huo, L. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.10.030 · Cited by 99

Redox Activation of p21 Cip1/WAF1/Sdi1 : A Multifunctional Regulator of Cell Survival and Death

O’Reilly, M. A. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.108 · Cited by 98

Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

Satyamoorthy, K., Chehab, N. H., Waterman, M. J. F., Lien, M. C., El‐Deiry, W. S., Herlyn, M., & Halazonetis, T. D. (2000) · PubMed · Cited by 98

Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

Song, B., Yang, P., & Zhang, S. (2024) · 癌症：英文版 · doi:10.1002/cac2.12520 · Cited by 103

14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers

Rajagopalan, S., Jaulent, A. M., Wells, M. A., Veprintsev, D. B., & Fersht, A. R. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn598 · Cited by 98

Bidentate Ligands on Osmium(VI) Nitrido Complexes Control Intracellular Targeting and Cell Death Pathways

Suntharalingam, K., Johnstone, T. C., Bruno, P. M., Wei, L., Hemann, M. T., & Lippard, S. J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4075375 · Cited by 100

p53 α-Helix mimetics antagonize p53/MDM2 interaction and activate p53

Chen, L., Yin, H. H., Farooqi, B., Sebti, S. M., Hamilton, A. D., & Chen, J. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0342 · Cited by 97

p53 Mediates Nontranscriptional Cell Death in Dopaminergic Cells in Response to Proteasome Inhibition

Nair, V. D., McNaught, K. S. P., González‐Maeso, J., Sealfon, S. C., & Olanow, C. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603950200 · Cited by 101

Autophosphorylation of p110δ phosphoinositide 3‐kinase: a new paradigm for the regulation of lipid kinases in vitro and in vivo

Vanhaesebroeck, B., Higashi, K., Raven, C., Welham, M., Anderson, S., Brennan, P., Ward, S. G., & Waterfield, M. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1292 · Cited by 97

Involvement of c‐jun NH2‐terminal kinases in resveratrol‐induced activation of p53 and apoptosis

She, Q., Huang, C., Zhang, Y., & Dong, Z. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10041 · Cited by 97

p53-Independent Effects of Mdm2

Bohlman, S., & Manfredi, J. J. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_13 · Cited by 98

Gadd45a contributes to p53 stabilization in response to DNA damage

Jin, S., Mazzacurati, L., Zhu, X., Tong, T., Song, Y., Shao, S., Petrik, K. L., Rajasekaran, B., Wu, M., & Zhan, Q. (2003) · Oncogene · doi:10.1038/sj.onc.1206907 · Cited by 99

S100A4 interacts with p53 in the nucleus and promotes p53 degradation

Orre, L. M., Panizza, E., Kaminskyy, V. O., Vernet, E., Gräslund, T., Zhivotovsky, B., & Lehtiö, J. (2013) · Oncogene · doi:10.1038/onc.2013.213 · Cited by 102

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin

Gutekunst, M., Oren, M., Weilbacher, A., Dengler, M. A., Markwardt, C., Thomale, J., Aulitzky, W. E., & van der Kuip, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019198 · Cited by 100

Distinct pattern of p53 phosphorylation in human tumors

Minamoto, T., Buschmann, T., Habelhah, H., Matusevich, E., Tahara, H., Børresen‐Dale, A., Harris, C. C., Sidransky, D., & Ronai, Z. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204458 · Cited by 96

The N-Terminal Domain of p73 Interacts with the CH1 Domain of p300/CREB Binding Protein and Mediates Transcriptional Activation and Apoptosis

Zeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 97

Role for p300 in Stabilization of p53 in the Response to DNA Damage

Yuan, Z.-M., Huang, Y., Ishiko, T., Nakada, S., Utsugisawa, T., Shioya, H., Utsugisawa, Y., Yokoyama, K. K., Weichselbaum, R. R., Shi, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1883 · Cited by 97

Activation of p53 by Oxidative Stress Involves Platelet-derived Growth Factor-β Receptor-mediated Ataxia Telangiectasia Mutated (ATM) Kinase Activation

Chen, K., Albano, A., Ho, A., & Keaney, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304423200 · Cited by 95

Met acts on Mdm2 via mTOR to signal cell survival during development

Moumen, A., Patané, S., Porras, A., Dono, R., & Maina, F. (2007) · Development · doi:10.1242/dev.02820 · Cited by 95

Do Mutations Turn p53 into an Oncogene?

Pitolli, C., Wang, Y., Mancini, M., Shi, Y., Melino, G., & Amelio, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246241 · Cited by 97

Flexible lid to the p53-binding domain of human Mdm2: Implications for p53 regulation

McCoy, M. A., Gesell, J. J., Senior, M. M., & Wyss, D. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0334477100 · Cited by 96

MDM2 and MDMX can interact differently with ARF and members of the p53 family

Wang, X., Arooz, T., Siu, W. Y., Chiu, C. H. S., Lau, A., Yamashita, K., & Poon, R. Y. C. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02124-x · Cited by 94

p53–Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback

Wagner, J., Ma, L., Rice, J. J., Hu, W., Levine, A. J., & Stolovitzky, G. A. (2005) · Systems Biology · doi:10.1049/ip-syb:20050025 · Cited by 95

Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities

Li, D. W.-C., Liu, J.-P., Schmid, P. C., Schlosser, R., Feng, H., Liu, W.-B., Yan, Q., Gong, L., Sun, S.-M., Deng, M., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209334 · Cited by 98

6-OHDA generated ROS induces DNA damage and p53- and PUMA-dependent cell death

Bernstein, A. I., Garrison, S. P., Zambetti, G. P., & O’Malley, K. L. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-2 · Cited by 96

Interfering in apoptosis and DNA repair of cancer cells to conquer cisplatin resistance by platinum( iv ) prodrugs

Zhang, S., Zhong, X., Yuan, H., Guo, Y., Song, D., Qi, F., Zhu, Z., Wang, X., & Guo, Z. (2020) · Chemical Science · doi:10.1039/d0sc00197j · Cited by 94

Phosphatases in the cellular response to DNA damage

Freeman, A. K., & Monteiro, Á. N. A. (2010) · Cell Communication and Signaling · doi:10.1186/1478-811x-8-27 · Cited by 104

mdm2: a bridge over the two tumour suppressors, p53 and Rb

Yap, D., Hsieh, J.-K., Chan, F., & Lü, X. (1999) · Oncogene · doi:10.1038/sj.onc.1202954 · Cited by 93

Mdm2 in the Response to Radiation

Perry, M. E. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.9.2.1 · Cited by 96

Inhibition of p53‐dependent transcription by BOX‐I phospho‐peptide mimetics that bind to p300

Dornan, D., & Hupp, T. R. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve025 · Cited by 93

Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation

Damia, G. L. M., Filiberti, L., Vikhanskaya, F., Carrassa, L., Taya, Y., D’Incalci, M., & Broggini, M. (2001) · Neoplasia · doi:10.1038/sj.neo.7900122 · Cited by 96

A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response

Benatti, P., Basile, V., Merico, D., Fantoni, L. I., Tagliafico, E., & Imbriano, C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkm1046 · Cited by 92

Untitled work

(1997) · PubMed · Cited by 243

Human DNA-Activated Protein Kinase Phosphorylates Serines 15 and 37 in the Amino-Terminal Transactivation Domain of Human p53

Lees‐Miller, S. P., Sakaguchi, K., Ullrich, S. J., Appella, E., & Anderson, C. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.11.5041-5049.1992 · Cited by 487

DNA damage‐inducible phosphorylation of p53 at Ser20 is required for p53 stabilization

Yang, D., Rhee, B. K., Yim, T. H., Lee, H. J., & Kim, J. (2002) · Korean Journal of Biological Sciences · doi:10.1080/12265071.2002.9647661

Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage.

Chehab, N. H., Malikzay, A., Stavridi, E. S., & Halazonetis, T. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13777 · Cited by 583

ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage

Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 731